EEG microstate complexity for aiding early diagnosis of Alzheimer's disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 10 2020
Historique:
received: 10 03 2020
accepted: 05 10 2020
entrez: 20 10 2020
pubmed: 21 10 2020
medline: 20 1 2021
Statut: epublish

Résumé

The dynamics of the resting brain exhibit transitions between a small number of discrete networks, each remaining stable for tens to hundreds of milliseconds. These functional microstates are thought to be the building blocks of spontaneous consciousness. The electroencephalogram (EEG) is a useful tool for imaging microstates, and EEG microstate analysis can potentially give insight into altered brain dynamics underpinning cognitive impairment in disorders such as Alzheimer's disease (AD). Since EEG is non-invasive and relatively inexpensive, EEG microstates have the potential to be useful clinical tools for aiding early diagnosis of AD. In this study, EEG was collected from two independent cohorts of probable AD and cognitively healthy control participants, and a cohort of mild cognitive impairment (MCI) patients with four-year clinical follow-up. The microstate associated with the frontoparietal working-memory/attention network was altered in AD due to parietal inactivation. Using a novel measure of complexity, we found microstate transitioning was slower and less complex in AD. When combined with a spectral EEG measure, microstate complexity could classify AD with sensitivity and specificity > 80%, which was tested on an independent cohort, and could predict progression from MCI to AD in a small preliminary test cohort of 11 participants. EEG microstates therefore have potential to be a non-invasive functional biomarker of AD.

Identifiants

pubmed: 33077823
doi: 10.1038/s41598-020-74790-7
pii: 10.1038/s41598-020-74790-7
pmc: PMC7572485
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17627

Subventions

Organisme : Alzheimer's Society
ID : 231
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT105618MA
Pays : United Kingdom

Références

Neuroimage. 2016 Jan 15;125:643-656
pubmed: 26285079
Lancet Neurol. 2007 Aug;6(8):734-46
pubmed: 17616482
Sci Rep. 2017 Jul 18;7(1):5775
pubmed: 28720796
Front Neurosci. 2019 Jun 11;13:563
pubmed: 31263397
J Am Geriatr Soc. 2003 May;51(5 Suppl Dementia):S281-8
pubmed: 12801384
Lancet Neurol. 2014 Jun;13(6):614-29
pubmed: 24849862
Brain Res. 2018 Jan 1;1678:262-272
pubmed: 29079506
Neuroimage. 2017 Feb 1;146:533-543
pubmed: 27742598
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Neuroimage. 2015 Aug 15;117:449-55
pubmed: 26032884
J Alzheimers Dis. 2011;25(2):309-21
pubmed: 21422523
Psychiatry Res. 1997 Oct 31;75(3):183-91
pubmed: 9437775
Brain. 1999 Mar;122 ( Pt 3):383-404
pubmed: 10094249
Lancet Neurol. 2006 Mar;5(3):228-34
pubmed: 16488378
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18179-84
pubmed: 20921381
Alzheimers Res Ther. 2015 Dec 31;7:78
pubmed: 26718102
Front Aging Neurosci. 2013 Oct 03;5:58
pubmed: 24106478
J Neural Transm (Vienna). 1997;104(4-5):483-95
pubmed: 9295180
Neuroimage Clin. 2019;24:102046
pubmed: 31795039
Int J Alzheimers Dis. 2011 Apr 13;2011:539621
pubmed: 21584257
CNS Neurosci Ther. 2012 Apr;18(4):285-94
pubmed: 22070283
Psychopharmacology (Berl). 2007 May;191(4):995-1004
pubmed: 17333135
Int J Psychophysiol. 2016 May;103:88-102
pubmed: 25660305
Neuroimage. 2010 Oct 1;52(4):1149-61
pubmed: 20139014
Eur Arch Psychiatry Clin Neurosci. 1998;248(5):259-66
pubmed: 9840373
Clin Neurophysiol. 2013 Jun;124(6):1106-14
pubmed: 23403263
JAMA. 2009 Jul 22;302(4):385-93
pubmed: 19622817
Neurosci Biobehav Rev. 2015 Feb;49:105-13
pubmed: 25526823
Brain. 2019 Jun 1;142(6):1767-1782
pubmed: 30938426
J Alzheimers Dis. 2016 Apr 18;52(3):1125-33
pubmed: 27104892
Eur Neurol. 1996;36(6):378-84
pubmed: 8954307
Psychiatry Res. 2005 Feb 28;138(2):141-56
pubmed: 15766637
Dement Geriatr Cogn Disord. 2010;29(5):432-7
pubmed: 20502017
Clin Neurophysiol. 2019 Sep;130(9):1581-1595
pubmed: 31306967
JAMA Neurol. 2013 Sep 1;70(9):1158-66
pubmed: 23835471
Neuroimage. 2002 May;16(1):41-8
pubmed: 11969316
Eur Arch Psychiatry Clin Neurosci. 1999;249(4):205-11
pubmed: 10449596
Psychiatry Res. 1993 Dec;50(4):275-82
pubmed: 8177925
Neuroimage. 2017 Sep;158:99-111
pubmed: 28673879
PLoS One. 2014 Dec 05;9(12):e114163
pubmed: 25479614
Clin Neurophysiol. 2007 Oct;118(10):2162-71
pubmed: 17765604
Neuropsychobiology. 1993;27(4):231-6
pubmed: 8232844
Int J Psychophysiol. 1998 Jun;29(1):1-11
pubmed: 9641243
Clin Neuropsychol. 2012;26(6):926-41
pubmed: 22809061
Brain Res Brain Res Rev. 2001 Oct;36(2-3):108-18
pubmed: 11690607
J Neurol Neurosurg Psychiatry. 2005 Jun;76 Suppl 2:ii2-7
pubmed: 15961864
Neuroimage. 2010 Oct 1;52(4):1162-70
pubmed: 20188188
Neuroimage. 2018 Oct 15;180(Pt B):577-593
pubmed: 29196270

Auteurs

Luke Tait (L)

Living Systems Institute, University of Exeter, Exeter, UK. TaitL2@cardiff.ac.uk.
EPSRC Centre for Predictive Modelling in Healthcare, University of Exeter, Exeter, UK. TaitL2@cardiff.ac.uk.
College of Engineering, Maths, and Physical Sciences, University of Exeter, Exeter, UK. TaitL2@cardiff.ac.uk.
Cardiff University Brain Research Imaging Centre, School of Psychology, Cardiff University, Maindy Road, Cardiff, CF24 4HQ, UK. TaitL2@cardiff.ac.uk.

Francesco Tamagnini (F)

School of Pharmacy, University of Reading, Reading, UK.
University of Exeter Medical School, Exeter, UK.

George Stothart (G)

Department of Psychology, University of Bath, Bath, UK.

Edoardo Barvas (E)

San Marino Neurological Unit, San Marino Hospital, San Marino, Republic of San Marino.

Chiara Monaldini (C)

San Marino Neurological Unit, San Marino Hospital, San Marino, Republic of San Marino.

Roberto Frusciante (R)

San Marino Neurological Unit, San Marino Hospital, San Marino, Republic of San Marino.

Mirco Volpini (M)

San Marino Neurological Unit, San Marino Hospital, San Marino, Republic of San Marino.

Susanna Guttmann (S)

San Marino Neurological Unit, San Marino Hospital, San Marino, Republic of San Marino.

Elizabeth Coulthard (E)

Translational Health Sciences, University of Bristol, Bristol, UK.

Jon T Brown (JT)

University of Exeter Medical School, Exeter, UK.

Nina Kazanina (N)

School of Psychological Science, University of Bristol, Bristol, UK.

Marc Goodfellow (M)

Living Systems Institute, University of Exeter, Exeter, UK.
EPSRC Centre for Predictive Modelling in Healthcare, University of Exeter, Exeter, UK.
College of Engineering, Maths, and Physical Sciences, University of Exeter, Exeter, UK.
Centre for Biomedical Modelling and Analysis, University of Exeter, Exeter, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH